Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Long

Showing results (631-640 of 831) with videos related to

Pageof 84
Sort By:
The FEBS Journal|January 21, 2022
DRAM-4 and DRAM-5 are compensatory regulators of autophagy and cell survival in nutrient-deprived conditionsValentin J A Barthet, Michaela Mrschtik, Elzbieta Kania, et al.
Methods in Enzymology|June 21, 2011
Using Caenorhabditis elegans to study serpinopathiesOlivia S Long, Sager J Gosai, Joon Hyeok Kwak, et al.
BMC Cardiovascular Disorders|April 13, 2011
Pulse wave velocity and carotid atherosclerosis in white and Latino patients with hypertensionMori J Krantz, Carlin S Long, Patrick Hosokawa, et al.
Cell Death and Differentiation|July 1, 2017
DRAM-3 modulates autophagy and promotes cell survival in the absence of glucoseM Mrschtik, J O'Prey, L Y Lao, et al.
American Journal of Physiology. Heart and Circulatory Physiology|December 13, 2005
The PPAR-alpha activator fenofibrate fails to provide myocardial protection in ischemia and reperfusion in pigsYa Xu, Li Lu, Clifford Greyson, et al.
Methods in Enzymology|February 27, 2017
Application of CRISPR/Cas9 to Autophagy ResearchJ O'Prey, J Sakamaki, A D Baudot, et al.
American Journal of Physiology. Heart and Circulatory Physiology|April 6, 2010
AFos inhibits phenylephrine-mediated contractile dysfunction by altering phospholamban phosphorylationMark Y Jeong, John S Walker, R Dale Brown, et al.
Journal of Pharmaceutical Sciences|July 1, 1971
Spasmolytics. IV. Azo and azoxy derivatives of 3-tropanyl 2,3-diarylacrylatesH C Caldwell, J A Finkelstein, P P Goldman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1997
Phase I and pharmacological study of CI-980, a novel synthetic antimicrotubule agentE K Rowinsky, G S Long, D A Noe, et al.
Pediatric Research|October 15, 2008
Modeling molecular and cellular aspects of human disease using the nematode Caenorhabditis elegansGary A Silverman, Cliff J Luke, Sangeeta R Bhatia, et al.
Pageof 84

Showing results (631-640 of 831) with videos related to

Sort By:
Pageof 84
The FEBS Journal|January 21, 2022
DRAM-4 and DRAM-5 are compensatory regulators of autophagy and cell survival in nutrient-deprived conditionsValentin J A Barthet, Michaela Mrschtik, Elzbieta Kania, et al.
Methods in Enzymology|June 21, 2011
Using Caenorhabditis elegans to study serpinopathiesOlivia S Long, Sager J Gosai, Joon Hyeok Kwak, et al.
BMC Cardiovascular Disorders|April 13, 2011
Pulse wave velocity and carotid atherosclerosis in white and Latino patients with hypertensionMori J Krantz, Carlin S Long, Patrick Hosokawa, et al.
Cell Death and Differentiation|July 1, 2017
DRAM-3 modulates autophagy and promotes cell survival in the absence of glucoseM Mrschtik, J O'Prey, L Y Lao, et al.
American Journal of Physiology. Heart and Circulatory Physiology|December 13, 2005
The PPAR-alpha activator fenofibrate fails to provide myocardial protection in ischemia and reperfusion in pigsYa Xu, Li Lu, Clifford Greyson, et al.
Methods in Enzymology|February 27, 2017
Application of CRISPR/Cas9 to Autophagy ResearchJ O'Prey, J Sakamaki, A D Baudot, et al.
American Journal of Physiology. Heart and Circulatory Physiology|April 6, 2010
AFos inhibits phenylephrine-mediated contractile dysfunction by altering phospholamban phosphorylationMark Y Jeong, John S Walker, R Dale Brown, et al.
Journal of Pharmaceutical Sciences|July 1, 1971
Spasmolytics. IV. Azo and azoxy derivatives of 3-tropanyl 2,3-diarylacrylatesH C Caldwell, J A Finkelstein, P P Goldman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1997
Phase I and pharmacological study of CI-980, a novel synthetic antimicrotubule agentE K Rowinsky, G S Long, D A Noe, et al.
Pediatric Research|October 15, 2008
Modeling molecular and cellular aspects of human disease using the nematode Caenorhabditis elegansGary A Silverman, Cliff J Luke, Sangeeta R Bhatia, et al.
Pageof 84